 , Agents Acting on the Renin-Angiotensin System , Agents causing angioedema , Agents causing hyperkalemia , Angiotensin 2 Receptor Blocker , Angiotensin II receptor antagonists , Angiotensin II receptor blockers (ARBs) and calcium channel blockers , Angiotensin II receptor blockers (ARBs) and diuretics , Angiotensin II receptor blockers (ARBs), plain , Angiotensin II Type 1 Receptor Blockers , Angiotensin II Type 2 Receptor Blockers , Angiotensin Receptor Antagonists , Antiarrhythmic agents , Antihypertensive Agents , Antihypertensive Agents Indicated for Hypertension , Benzene Derivatives , Biphenyl Compounds , BSEP/ABCB11 Substrates , Cardiovascular Agents , Cytochrome P-450 CYP2C19 Inhibitors , Cytochrome P-450 CYP2C19 inhibitors (strength unknown) , Cytochrome P-450 CYP2C8 Inhibitors , Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) , Cytochrome P-450 CYP2C9 Substrates , Cytochrome P-450 CYP3A Inhibitors , Cytochrome P-450 CYP3A Substrates , Cytochrome P-450 CYP3A4 Inhibitors , Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) , Cytochrome P-450 CYP3A4 Substrates , Cytochrome P-450 Enzyme Inhibitors , Cytochrome P-450 Substrates , Drugs causing inadvertant photosensitivity , Hypotensive Agents , Imidazoles , OAT1/SLC22A6 inhibitors , P-glycoprotein inhibitors , P-glycoprotein substrates , Photosensitizing Agents , Potential QTc-Prolonging Agents , QTc Prolonging Agents , Tetrazoles , UGT1A1 Substrates , UGT1A3 substrates , UGT2B17 substrates , UGT2B7 substrates